iFabric Corp Updates Timing of EPA Public Health Claims Approval
iFabric Corp (TSX:IFA)(OTCQX:IFABF) announced an anticipated EPA approval for public health claims regarding PROTX2-treated fabrics. The approval from the U.S. Environmental Protection Agency is expected in Q1 2022. This registration is considered groundbreaking by Giancarlo Beevis, President and CEO of iFabric's subsidiary, Intelligent Fabrics Technologies (North America) Inc., impacting various applications from medical apparel to consumer goods. iFabric currently has 29.6 million shares outstanding, focusing on intelligent fabric treatments.
- Anticipated EPA approval for public health claims could enhance product credibility and market acceptance.
- The approval is viewed as a groundbreaking opportunity for multiple product applications.
- None.
MARKHAM, ON / ACCESSWIRE / January 17, 2022 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF), is pleased to provide an update on the timing of anticipated United States Environmental Protection Agency ("EPA") approval of the public health claims application submitted to the EPA by its wholly-owned subsidiary, Intelligent Fabrics Technologies (North America) Inc. ("IFTNA").
Specifically, representatives of the EPA have committed to provide approval of public health claims for PROTX2-treated fabrics within the first quarter of calendar 2022.
"I believe this registration will be groundbreaking for IFTNA, with far reaching implications across numerous product applications, from the medical apparel market to consumer goods," said Giancarlo Beevis, President and CEO of IFTNA.
ABOUT iFABRIC CORP:
Headquartered in Markham, Ontario, iFabric, www.ifabriccorp.com, is listed on the TSX and currently has 29.6 million shares issued and outstanding. Its two strategic divisions offer a variety of products and services through wholly-owned subsidiaries, namely, Intelligent Fabric Technologies (North America) Inc. ("IFTNA") and Coconut Grove Pads Inc. ("Coconut Grove").
IFTNA is focused on development and sale of high-performance sports apparel, medical protective apparel, consumer protective apparel, and proprietary treatments that provide "intelligent" properties to fabrics, foams, plastics, and numerous other surfaces, thereby improving the safety and well-being of the user. Such intelligent properties include antiviral and antibacterial characteristics, water-repellence and UV protection, among others.
Coconut Grove, operating as Coconut Grove Intimates, is a designer, manufacturer, distributor, licensor and licensee of ladies' intimate apparel products and accessories.
FORWARD LOOKING STATEMENTS
Forward-looking statements provide an opinion as to the effect of certain events and trends on the business. Certain statements contained in this news release constitute forward looking statements. The use of any words such as "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Forward-looking information includes, but is not limited to, statements with respect to the development potential of the company's products and its current or future sales or earnings results.
Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. Readers are cautioned not to place undue reliance on these statements as the Company's actual results, performance, or achievements may differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements if known or unknown risks, uncertainties or other factors affect the Company's business, or if the Company's estimates or assumptions prove inaccurate. Therefore, the Company cannot provide any assurance that forward-looking statements will materialize. The Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or any other reason except as required by applicable securities laws.
Any financial outlook or future oriented financial information in this news release, as defined by applicable securities legislation, has been approved by management of iFabric. Such financial outlook or future oriented financial information is provided for the purpose of providing information about management's reasonable expectations as to the anticipated results of its proposed business activities. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The forward-looking statements contained in this press release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.
FOR FURTHER INFORMATION, please contact:
Hilton Price, CFO
Tel: 647.465.6161
Email: hilton.price@rogers.com
Jessica Butt - Investor Relations
Tel: 416.844.6202
Email: jessica@adcap.ca
Website: www.ifabriccorp.com
Neither the TSX Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this press release.
SOURCE: iFabric Corp
View source version on accesswire.com:
https://www.accesswire.com/683655/iFabric-Corp-Updates-Timing-of-EPA-Public-Health-Claims-Approval
FAQ
What is the expected timing for EPA approval for iFabric Corp's public health claims?
What impact does the EPA approval have on iFabric Corp's products?
What is the significance of the PROTX2 treatment for iFabric Corp?
